These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 34961753

  • 1. Ultra-Short Course of Neo-Adjuvant Denosumab for Nerve-Sparing Surgery for Giant Cell Tumor of Bone in Sacrum.
    Liang H, Liu X, Yang Y, Guo W, Yang R, Tang X, Yan T, Li Y, Tang S, Li D, Qu H, Dong S, Ji T, Du Z, Zang J.
    Spine (Phila Pa 1976); 2022 May 01; 47(9):691-701. PubMed ID: 34961753
    [Abstract] [Full Text] [Related]

  • 2. The efficacy and safety of short-course neoadjuvant denosumab for en bloc spondylectomy in spinal giant cell tumor of bone: a preliminary report.
    Tang Q, Lu J, Zhu X, Song G, Wu H, Xu H, Wang A, Wang J.
    Eur Spine J; 2023 Dec 01; 32(12):4297-4305. PubMed ID: 37318598
    [Abstract] [Full Text] [Related]

  • 3. Short-term Preoperative Denosumab With Surgery in Unresectable or Recurrent Giant Cell Tumor of Bone.
    Zhang RZ, Ma TX, Qi DW, Zhao M, Hu T, Zhang GC.
    Orthop Surg; 2019 Dec 01; 11(6):1101-1108. PubMed ID: 31762217
    [Abstract] [Full Text] [Related]

  • 4. Is a Short-course of Preoperative Denosumab as Effective as Prolonged Therapy for Giant Cell Tumor of Bone?
    Hindiskere S, Errani C, Doddarangappa S, Ramaswamy V, Rai M, Chinder PS.
    Clin Orthop Relat Res; 2020 Nov 01; 478(11):2522-2533. PubMed ID: 32401001
    [Abstract] [Full Text] [Related]

  • 5. Retrospective cohort study of 68 sacral giant cell tumours treated with nerve-sparing surgery and evaluation on therapeutic benefits of denosumab therapy.
    Lim CY, Liu X, He F, Liang H, Yang Y, Ji T, Yang R, Guo W.
    Bone Joint J; 2020 Feb 01; 102-B(2):177-185. PubMed ID: 32009426
    [Abstract] [Full Text] [Related]

  • 6. Preoperative Denosumab With Curettage and Cryotherapy in Giant Cell Tumor of Bone: Is There an Increased Risk of Local Recurrence?
    Scoccianti G, Totti F, Scorianz M, Baldi G, Roselli G, Beltrami G, Franchi A, Capanna R, Campanacci DA.
    Clin Orthop Relat Res; 2018 Sep 01; 476(9):1783-1790. PubMed ID: 30778015
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of Local Recurrence in Giant-Cell Tumor of Bone Treated by Neoadjuvant Denosumab.
    Chinder PS, Hindiskere S, Doddarangappa S, Pal U.
    Clin Orthop Surg; 2019 Sep 01; 11(3):352-360. PubMed ID: 31475058
    [Abstract] [Full Text] [Related]

  • 8. Preoperative denosumab treatment with curettage may be a risk factor for recurrence of giant cell tumor of bone.
    Sano K, Suehara Y, Okubo T, Sasa K, Kurihara T, Akaike K, Kubota D, Torigoe T, Hasegawa N, Ishii M, Nakamura Y, Kim Y, Takagi T, Kaneko K, Hayashi T, Saito T.
    J Orthop Surg (Hong Kong); 2020 Sep 01; 28(2):2309499020929786. PubMed ID: 32539628
    [Abstract] [Full Text] [Related]

  • 9. Denosumab Treatment for Giant Cell Tumor of the Spine Including the Sacrum.
    Bukata SV, Blay JY, Rutkowski P, Skubitz K, Henshaw R, Seeger L, Dai T, Jandial D, Chawla S.
    Spine (Phila Pa 1976); 2021 Mar 01; 46(5):277-284. PubMed ID: 33038190
    [Abstract] [Full Text] [Related]

  • 10. The role of Denosumab in joint preservation for patients with giant cell tumour of bone.
    Perrin DL, Visgauss JD, Wilson DA, Griffin AM, Abdul Razak AR, Ferguson PC, Wunder JS.
    Bone Joint J; 2021 Jan 01; 103-B(1):184-191. PubMed ID: 33380180
    [Abstract] [Full Text] [Related]

  • 11. Combined preoperative denosumab and adjuvant microwave ablation for high-risk giant cell tumor of bone: a retrospective study in a single center.
    Zheng C, Xu G, Zhou X, Qiu J, Lan T, Zhang S, Li W.
    J Orthop Surg Res; 2024 Aug 17; 19(1):488. PubMed ID: 39154187
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect evaluation of denosumab combined with curettage and bone cement reconstruction in the treatment of recurrent giant cell tumor of bone around the knee joint.
    Duan DK, Zhang GC, Sun BJ, Ma TX, Zhao M.
    Eur Rev Med Pharmacol Sci; 2023 Jun 17; 27(11):5039-5052. PubMed ID: 37318478
    [Abstract] [Full Text] [Related]

  • 14. Neoadjuvant denosumab: its role and results in operable cases of giant cell tumour of bone.
    Puri A, Gulia A, Hegde P, Verma V, Rekhi B.
    Bone Joint J; 2019 Feb 17; 101-B(2):170-177. PubMed ID: 30700112
    [Abstract] [Full Text] [Related]

  • 15. Denosumab combined with en bloc resection and arthrodesis for recurrent grade 3 giant cell tumor of bone in distal radius.
    Li Z, Deng Z, Yang Y, Gao D, Zhang Q, Niu X, Liu W.
    J Orthop Surg Res; 2024 Sep 28; 19(1):607. PubMed ID: 39342379
    [Abstract] [Full Text] [Related]

  • 16. Intralesional nerve-sparing surgery versus non-surgical treatment for giant cell tumor of the sacrum.
    Tsukamoto S, Ali N, Mavrogenis AF, Honoki K, Tanaka Y, Spinnato P, Donati DM, Errani C.
    BMC Musculoskelet Disord; 2021 Dec 06; 22(1):1023. PubMed ID: 34872538
    [Abstract] [Full Text] [Related]

  • 17. Effect of denosumab in treatment of unresectable spine and sacrum giant cell tumor of bone.
    Arefpour A, Shafieesabet M, Chehrassan M, Ahmadzadehnanva A, Ghandhari H.
    Musculoskelet Surg; 2024 Mar 06; 108(1):93-98. PubMed ID: 37940782
    [Abstract] [Full Text] [Related]

  • 18. Clinical, radiological and pathological outcomes following treatment of primary giant cell tumour of bone with Denosumab.
    Murphy B, Vodanovich D, Spelman T, Gullifer J, Slavin J, Powell G, Pang G, Choong P.
    ANZ J Surg; 2020 Dec 06; 90(12):2553-2558. PubMed ID: 32767541
    [Abstract] [Full Text] [Related]

  • 19. Denosumab May Increase the Risk of Local Recurrence in Patients with Giant-Cell Tumor of Bone Treated with Curettage.
    Errani C, Tsukamoto S, Leone G, Righi A, Akahane M, Tanaka Y, Donati DM.
    J Bone Joint Surg Am; 2018 Mar 21; 100(6):496-504. PubMed ID: 29557866
    [Abstract] [Full Text] [Related]

  • 20. Current concepts in the treatment of giant cell tumour of bone.
    van der Heijden L, Dijkstra S, van de Sande M, Gelderblom H.
    Curr Opin Oncol; 2020 Jul 21; 32(4):332-338. PubMed ID: 32541321
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.